
Synteny is an AI-driven platform focused on decoding biology to accelerate disease discoveries by analyzing immune data. The company leverages high-throughput data and generative AI to design precision TCR bispecific therapies, targeting immune repertoires for biotech research and pharmaceutical applications. Their team combines expertise in computer science, immunology, mathematics, and engineering to build advanced AI tools that power disease research and therapeutic development. Synteny collaborates with partners like the MRC Clinical Trials Unit at UCL, positioning itself as a cutting-edge player in precision immunotherapy and drug discovery.

Synteny is an AI-driven platform focused on decoding biology to accelerate disease discoveries by analyzing immune data. The company leverages high-throughput data and generative AI to design precision TCR bispecific therapies, targeting immune repertoires for biotech research and pharmaceutical applications. Their team combines expertise in computer science, immunology, mathematics, and engineering to build advanced AI tools that power disease research and therapeutic development. Synteny collaborates with partners like the MRC Clinical Trials Unit at UCL, positioning itself as a cutting-edge player in precision immunotherapy and drug discovery.